KIR3DL1 and non-Hodgkin lymphoma: The higher frequency of KIR3DL1/Bw6 combination found in NHL (Fig. 4) suggests that a HLA-Bw6/antigen-derived complex originating during HCV infection might constitute a signal for the inhibitory KIR3DL1 receptor, as previously demonstrated in other viral situations [39–41].